Building a biotechnology company? Check this Indication Checklist.

Biotechnology companies must carefully consider the choice of the first disease indication for their new drug. There are several key elements that can help guide this critical decision. Drawing on years of experience, this article provides an 'Indication Checklist' with recommendations designed to help.